The antiacetylcholinesterase and antileishmanial activities of canarium patentinervium Miq.

34Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In continuation of our natural and medicinal research programme on tropical rainforest plants, a bioassay guided fractionation of ethanolic extract of leaves of Canarium patentinervium Miq. (Burseraceae Kunth.) led to the isolation of scopoletin (1), scoparone (2), (+)-catechin (3), vomifoliol (4), lioxin (5), and syringic acid (6). All the compounds exhibited antiacetylcholinesterase activity with syringic acid, a phenolic acid exhibiting good AChE inhibition (IC50 29.53 ± 0.19 g/mL). All compounds displayed moderate antileishmanial activity with scopoletin having the highest antileishmanial activity (IC50 163.30 ± 0.32 g/mL). Given the aforementioned evidence, it is tempting to speculate that Canarium patentinervium Miq. represents an exciting scaffold from which to develop leads for treatment of neurodegenerative and parasitic diseases. © 2014 R. Mogana et al.

Cite

CITATION STYLE

APA

Mogana, R., Adhikari, A., Debnath, S., Hazra, S., Hazra, B., Teng-Jin, K., & Wiart, C. (2014). The antiacetylcholinesterase and antileishmanial activities of canarium patentinervium Miq. BioMed Research International, 2014. https://doi.org/10.1155/2014/903529

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free